Observation on the efficacy of Eustachian tube dilation hormone under the guidance of endoscope in the treatment of sudden deafness
-
摘要: 目的 评估耳内镜引导下导管法咽鼓管吹张激素治疗突发性聋患者的疗效。方法 选取2020年1月-2020年12月就诊于陕西省人民医院耳鼻咽喉头颈外科的突发性聋高频下降型患者, 根据纳入及排除标准纳入176例患者(185耳)作为研究对象, 以随机数字表法分成对照组86例(90耳)和研究组90例(95耳)。对照组予以鼓室注射甲泼尼龙(即注射用甲泼尼龙琥珀酸钠)治疗, 研究组用耳内镜下咽鼓管鼓室吹张甲泼尼龙治疗, 比较两组患者治疗前后纯音听阈值、有效率及用药期间不良反应发生率。结果 研究组治疗总有效率为84.21%(80/95), 略低于对照组的有效率84.44%(76/90), 但两组比较差异无统计学意义(P>0.05)。两组纯音听阈值较治疗前明显提高, 研究组听力平均提高(25.47±6.29) dB, 略低于对照组(27.33±7.55) dB, 两组比较差异无统计学意义(P>0.05);两组治疗方式出现轻微不良反应的发生率比较, 差异无统计学意义(P>0.05)。均未出现严重不良反应。结论 耳内镜下咽鼓管鼓室吹张激素治疗突发性聋患者在治疗总有效率、听力提高水平、不良反应率等方面与鼓室注射激素治疗效果相同。Abstract: Objective To evaluate the efficacy of Eustachian tube dilation hormone under the guidance of otoscope in the treatment of patients with sudden deafness.Methods One hundred and seventy-six patients(185 ears) with sudden deafness treated by otorhinolaryngology head and neck surgery in Shaanxi Provincial People's Hospital from January 2020 to December 2020 were selected. According to the inclusion and exclusion criteria, 176 patients(185 ears) were randomly divided into control group(n=86, 90 ears) and study group(n=90, 95 ears). The control group was treated with intratympanic injection of methylprednisolone(methylprednisolone sodium succinate for injection), and the study group was treated with tympanic tympanoplasty under otoendoscope. The pure tone hearing threshold, effective rate and the incidence of adverse reactions were compared between the two groups before and after treatment.Results The total effective rate of the study group was 84.21%(80/95), slightly lower than that of the control group(84.44%), but there was no significant difference between the two groups. The hearing threshold of pure tone in the two groups was significantly higher than that before treatment, and the average improvement of hearing in the study group(25.47±6.29) dB was slightly lower than that in the control group(27.33±7.55) dB, but there was no significant difference between the two groups(P>0.05). There was no significant difference in the incidence of mild adverse reactions between the two groups(P>0.05). There were no serious adverse reactions.Conclusion The total effective rate, hearing improvement level and adverse reaction rate of patients with sudden deafness treated with Eustachian tube tympanic dilatation hormone under endoscope are the same as that of tympanic hormone injection.
-
Key words:
- sudden deafness /
- endoscope /
- Eustachian tube dilatation by catheter /
- hormones
-
-
表 1 两组临床疗效比较
耳(%) 组别 耳数 痊愈 显效 有效 无效 总有效 研究组 95 16(16.84) 26(27.37) 38(40.00) 15(15.79) 80(84.21) 对照组 90 13(14.44) 25(27.78) 38(42.22) 14(15.56) 76(84.44) 
下载: 导出CSV
表 2 两组治疗前后听阈平均值比较
dB HL 组别 耳数 治疗前 听力提高 研究组 95 54.45±7.43 25.47±6.29 对照组 90 56.17±8.30 27.33±7.55
下载: 导出CSV
表 3 两组患者的不良反应情况比较
耳(%) 组别 耳数 短暂性眩晕 耳部不适 消化道不良反应 研究组 95 12(12.63) 15(15.79) 5(5.26) 对照组 90 14(15.56) 18(20.00) 7(7, 78)
下载: 导出CSV
-
[1] 中华耳鼻咽喉头颈外科杂志编辑委员会, 中华医学会耳鼻咽喉头颈外科学分会. 突发性聋诊断和治疗指南(2015)[J]. 中华耳鼻咽喉头颈外科杂志, 2015, 50(6): 443-447. doi: 10.3760/cma.j.issn.1673-0860.2015.06.002
[2] Gul F, Muderris T, Yalciner G, et al. A comprehensive study of oxidative stress in sudden hearing loss[J]. Eur Arch Otorhinolaryngol, 2017, 274(3): 1301-1308. doi: 10.1007/s00405-016-4301-1
[3] Jung SY, Shim HS, Hah YM, et al. Association of Metabolic Syndrome With Sudden Sensorineural Hearing Loss[J]. JAMA Otolaryngol Head Neck Surg, 2018, 144(4): 308-314. doi: 10.1001/jamaoto.2017.3144
[4] Watanabe H, Sano H, Maki A, et al. Investigation of Stress Levels before the Onset of Idiopathic Sudden Sensorineural Hearing Loss[J]. J Int Adv Otol, 2019, 15(1): 51-55. doi: 10.5152/iao.2019.6197
[5] 包小敏, 李谦, 余维, 等. 情绪障碍对突发性聋发病的影响[J]. 国际耳鼻咽喉头颈外科杂志, 2020, 44(4): 237-240. doi: 10.3760/cma.j.issn.1673-4106.2020.04.012
[6] 耿萍, 陈亚权. 鼓室注射与静脉滴注甲泼尼龙琥珀酸钠治疗突发性耳聋的疗效对比研究[J]. 现代药物与临床, 2017, 32(6): 1105-1008. https://www.cnki.com.cn/Article/CJFDTOTAL-GWZW201706034.htm
[7] Lechner M, Sutton L, Ferguson M, et al. Intratympanic Steroid Use for Sudden Sensorineural Hearing Loss: Current Otolaryngology Practice[J]. Ann Otol Rhinol Laryngol, 2019, 128(6): 490-502. doi: 10.1177/0003489419828759
[8] Chandrasekhar SS, Tsai Do BS, Schwartz SR, et al. Clinical Practice Guideline: Sudden Hearing Loss(Update)Executive Summary[J]. Otolaryngol Head Neck Surg, 2019, 161(2): 195-210. doi: 10.1177/0194599819859883
[9] Herrera M, García Berrocal JR, García Arumí A, et al. Update on consensus on diagnosis and treatment of idiopathic sudden sensorineural hearing loss[J]. Acta Otorrinolaringol Esp, 2019, 70(5): 290-300. doi: 10.1016/j.otorri.2018.04.010
[10] El Sabbagh NG, Sewitch MJ, Bezdjian A, et al. Intratympanic dexamethasone in sudden sensorineural hearing loss: A systematic review and meta-analysis[J]. Laryngoscope, 2017, 127(8): 1897-1908. doi: 10.1002/lary.26394
[11] Parnes LS, Sun AH, Freeman DJ. Corticosteroid pharmacokinetics in the inner ear fluids: an animal study followed by clinical application[J]. Laryngoscope, 1999, 109(7 Pt 2): 1-17.
[12] Rauch SD, Halpin CF, Antonelli PJ, et al. Oral vs intratympanic corticosteroid therapy for idiopathic sudden sensorineural hearing loss: a randomized trial[J]. JAMA, 2011, 305(20): 2071-2079. doi: 10.1001/jama.2011.679
[13] 中国突发性聋多中心临床研究协作组. 中国突发性聋分型治疗的多中心临床研究[J]. 中华耳鼻咽喉头颈外科杂志, 2013, 48(5): 355-361. doi: 10.3760/cma.j.issn.1673-0860.2013.05.002
[14] 刘焕娣. 鼻内镜下经咽鼓管鼓室内注入地塞米松辅助治疗突发性耳聋临床研究[J]. 现代中西医结合杂志, 2015, 24(22): 2484-2485. https://www.cnki.com.cn/Article/CJFDTOTAL-XDJH201522035.htm
[15] 孙卫蔚, 李立. 鼻内镜下经咽鼓管鼓室内注入地塞米松辅助治疗难治性突发性耳聋39例[J]. 临床医学, 2013, 33(3): 86-87. doi: 10.3969/j.issn.1003-3548.2013.03.050
[16] 李姝娜, 张帆, 杨军. 美国耳鼻咽喉头颈外科学会2019年突发性聋临床实践指南解读及与2012版指南的差异[J]. 临床耳鼻咽喉头颈外科杂志, 2020, 34(5): 385-388. https://www.cnki.com.cn/Article/CJFDTOTAL-LCEH202005001.htm
[17] 梁碧莹, 李希平. 鼓室注射或全身鼓室联合应用糖皮质激素挽救性治疗中重度突发性聋的疗效分析[J]. 临床耳鼻咽喉头颈外科杂志, 2020, 34(6): 536-540. https://www.cnki.com.cn/Article/CJFDTOTAL-LCEH202006015.htm
[18] Swachia K, Sharma D, Singh J. Efficacy of oral vs. intratympanic corticosteroids in sudden sensorineural hearing loss[J]. J Basic Clin Physiol Pharmacol, 2016, 27(4): 371-377.
[19] Ahmadzai N, Kilty S, Cheng W, et al. A systematic review and network meta-analysis of existing pharmacologic therapies in patients with idiopathic sudden sensorineural hearing loss[J]. PLoS One, 2019, 14(9): e0221713. doi: 10.1371/journal.pone.0221713
[20] Chotiyarnwong P, McCloskey EV. Pathogenesis of glucocorticoid-induced osteoporosis and options for treatment[J]. Nat Rev Endocrinol, 2020, 16(8): 437-447. doi: 10.1038/s41574-020-0341-0
[21] Ermutlu G, Süslü N, Yılmaz T, et al. Sudden hearing loss: an effectivity comparison of intratympanic and systemic steroid treatments[J]. Eur Arch Otorhinolaryngol, 2017, 274(10): 3585-3591. doi: 10.1007/s00405-017-4691-8
[22] Tsounis M, Psillas G, Tsalighopoulos M, et al. Systemic, intratympanic and combined administration of steroids for sudden hearing loss. A prospective randomized multicenter trial[J]. Eur Arch Otorhinolaryngol, 2018, 275(1): 103-110. doi: 10.1007/s00405-017-4803-5
[23] Lai D, Zhao F, Jalal N, et al. Intratympanic glucocorticosteroid therapy for idiopathic sudden hearing loss: Meta-analysis of randomized controlled trials[J]. Medicine(Baltimore), 2017, 96(50): e8955.
[24] 张志坚, 祝园平, 杨希林, 等. 鼓室内注射地塞米松治疗伴眩晕的全聋型突发性聋的疗效分析[J]. 听力学及言语疾病杂志, 2018, 26(6): 612-615. doi: 10.3969/j.issn.1006-7299.2018.06.011
[25] 颜艳萍, 雷晓兰. 咽鼓管吹张术后导管给药治疗分泌性中耳炎[J]. 实用临床医学, 2014, 15(3): 72-73. https://www.cnki.com.cn/Article/CJFDTOTAL-LCSY201403031.htm
[26] 庞湃, 于雅莲, 姜学钧, 等. 激素经导管法咽鼓管吹张治疗分泌性中耳炎[J]. 中华耳科学杂志, 2015, 13(4): 693-695. doi: 10.3969/j.issn.1672-2922.2015.04.029
-